Covering: 2000 to 2009 Myxobacteria are one of the most outstanding resources for microbial natural products. This review focuses on the impact of genomics on the evaluation and exploitation of their biosynthetic potential.
No takes yet. Share an insight, caveat, or question.
Wenzel et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: